BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34426515)

  • 21. Deletion of an X-inactivation boundary disrupts adjacent gene silencing.
    Horvath LM; Li N; Carrel L
    PLoS Genet; 2013 Nov; 9(11):e1003952. PubMed ID: 24278033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation profiling in X;autosome translocations supports a role for L1 repeats in the spread of X chromosome inactivation.
    Bala Tannan N; Brahmachary M; Garg P; Borel C; Alnefaie R; Watson CT; Thomas NS; Sharp AJ
    Hum Mol Genet; 2014 Mar; 23(5):1224-36. PubMed ID: 24186870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer.
    Winham SJ; Larson NB; Armasu SM; Fogarty ZC; Larson MC; McCauley BM; Wang C; Lawrenson K; Gayther S; Cunningham JM; Fridley BL; Goode EL
    Hum Mol Genet; 2019 Apr; 28(8):1331-1342. PubMed ID: 30576442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escape from X inactivation varies in mouse tissues.
    Berletch JB; Ma W; Yang F; Shendure J; Noble WS; Disteche CM; Deng X
    PLoS Genet; 2015 Mar; 11(3):e1005079. PubMed ID: 25785854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escape from X-inactivation in twins exhibits intra- and inter-individual variability across tissues and is heritable.
    Zito A; Roberts AL; Visconti A; Rossi N; Andres-Ejarque R; Nardone S; El-Sayed Moustafa JS; Falchi M; Small KS
    PLoS Genet; 2023 Feb; 19(2):e1010556. PubMed ID: 36802379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of X-Chromosome Inactivation in Retinal Development and Disease.
    Fahim AT; Daiger SP
    Adv Exp Med Biol; 2016; 854():325-31. PubMed ID: 26427428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autosomal genetic variation is associated with DNA methylation in regions variably escaping X-chromosome inactivation.
    Luijk R; Wu H; Ward-Caviness CK; Hannon E; Carnero-Montoro E; Min JL; Mandaviya P; Müller-Nurasyid M; Mei H; van der Maarel SM; ; Relton C; Mill J; Waldenberger M; Bell JT; Jansen R; Zhernakova A; Franke L; 't Hoen PAC; Boomsma DI; van Duijn CM; van Greevenbroek MMJ; Veldink JH; Wijmenga C; van Meurs J; Daxinger L; Slagboom PE; van Zwet EW; Heijmans BT
    Nat Commun; 2018 Sep; 9(1):3738. PubMed ID: 30218040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The probability to initiate X chromosome inactivation is determined by the X to autosomal ratio and X chromosome specific allelic properties.
    Monkhorst K; de Hoon B; Jonkers I; Mulugeta Achame E; Monkhorst W; Hoogerbrugge J; Rentmeester E; Westerhoff HV; Grosveld F; Grootegoed JA; Gribnau J
    PLoS One; 2009; 4(5):e5616. PubMed ID: 19440388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escape From X-Chromosome Inactivation: An Evolutionary Perspective.
    Posynick BJ; Brown CJ
    Front Cell Dev Biol; 2019; 7():241. PubMed ID: 31696116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strong Constraint on Human Genes Escaping X-Inactivation Is Modulated by their Expression Level and Breadth in Both Sexes.
    Slavney A; Arbiza L; Clark AG; Keinan A
    Mol Biol Evol; 2016 Feb; 33(2):384-93. PubMed ID: 26494842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bovine mammary gland X chromosome inactivation.
    Couldrey C; Johnson T; Lopdell T; Zhang IL; Littlejohn MD; Keehan M; Sherlock RG; Tiplady K; Scott A; Davis SR; Spelman RJ
    J Dairy Sci; 2017 Jul; 100(7):5491-5500. PubMed ID: 28477999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refining the genomic determinants underlying escape from X-chromosome inactivation.
    Peeters S; Leung T; Fornes O; Farkas RA; Wasserman WW; Brown CJ
    NAR Genom Bioinform; 2023 Jun; 5(2):lqad052. PubMed ID: 37260510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex chromosome inactivation in the male.
    Yan W; McCarrey JR
    Epigenetics; 2009 Oct; 4(7):452-6. PubMed ID: 19838052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-inactivation and human disease: X-linked dominant male-lethal disorders.
    Franco B; Ballabio A
    Curr Opin Genet Dev; 2006 Jun; 16(3):254-9. PubMed ID: 16650755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-Chromosome Inactivation and Related Diseases.
    Sun Z; Fan J; Wang Y
    Genet Res (Camb); 2022; 2022():1391807. PubMed ID: 35387179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development.
    Okamoto I; Patrat C; Thépot D; Peynot N; Fauque P; Daniel N; Diabangouaya P; Wolf JP; Renard JP; Duranthon V; Heard E
    Nature; 2011 Apr; 472(7343):370-4. PubMed ID: 21471966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escape from X Chromosome Inactivation and the Female Predominance in Autoimmune Diseases.
    Youness A; Miquel CH; Guéry JC
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosome-wide profiling of X-chromosome inactivation and epigenetic states in fetal brain and placenta of the opossum, Monodelphis domestica.
    Wang X; Douglas KC; Vandeberg JL; Clark AG; Samollow PB
    Genome Res; 2014 Jan; 24(1):70-83. PubMed ID: 24065774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional sexual dimorphism in elongating bovine embryos: implications for XCI and sex determination genes.
    Bermejo-Alvarez P; Rizos D; Lonergan P; Gutierrez-Adan A
    Reproduction; 2011 Jun; 141(6):801-8. PubMed ID: 21411694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-chromosome inactivation in monkey embryos and pluripotent stem cells.
    Tachibana M; Ma H; Sparman ML; Lee HS; Ramsey CM; Woodward JS; Sritanaudomchai H; Masterson KR; Wolff EE; Jia Y; Mitalipov SM
    Dev Biol; 2012 Nov; 371(2):146-55. PubMed ID: 22935618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.